Market closed · Next open: Monday 9:30 AM ET
Last update: Nov 20, 2026, 6:14 PM ET
Cytokinetics, Incorporated
▼ 12.7% on Nov 5, 2026

Why Cytokinetics, Incorporated (CYTK) Stock Fell 12.7% on Nov 5, 2026

Researched by BestStocks Market Desk · Published Nov 5, 2026
Prior close
$63.60
Nov 5, 2026 close
$55.55
Change
−$8.05
-12.66%
Rel. volume
3.5×
6.8M shares

What happened

Risk-12.7%high confidence

Cytokinetics filed a material event (8-K) and an earnings report today, triggering an 11.72% intraday decline to $56.15 from $63.60. Volume surged to 1.93M shares, 6.2x the historical average for this time of session, signaling heavy institutional repositioning on the news.

Source: fmp_intraday
What to watch next

Review the filed 8-K and earnings report details once available; monitor for management commentary on the driver of today's decline and any revised guidance or strategic updates ahead of the next confirmed earnings call (scheduled for February 2027).

Frequently asked questions

Why did Cytokinetics, Incorporated (CYTK) stock fall on Nov 5, 2026?

Cytokinetics filed a material event (8-K) and an earnings report today, triggering an 11.72% intraday decline to $56.15 from $63.60. Volume surged to 1.93M shares, 6.2x the historical average for this time of session, signaling heavy institutional repositioning on the news.

How much did CYTK stock fall on Nov 5, 2026?

CYTK fell 12.7% during the Nov 5, 2026 trading session.

This is an archived analysis of CYTK's Nov 5, 2026 session.
See CYTK's latest changes →
Educational research tool — not personalized investment advice. Figures reflect the Nov 5, 2026 session as first analyzed.